Furthermore, a study done using the California Cancer Registry Data also showed that higher IBC incidence rate is not dependent on HER2-status, as IBC patients had lower survival rates compared with other patients, regardless of HER2 positivity [29]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.